Published 17 May 2004. doi:10.1084/jem.20040111
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 10, 1391-1399
A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency
Morten Dahl1,
Anne Tybjærg-Hansen2,3,
Peter Schnohr3, and
Børge G. Nordestgaard1,3
1 Department of Clinical Biochemistry, Herlev University Hospital, DK-2730 Herlev, Denmark
2 Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark
3 The Copenhagen City Heart Study, Bispebjerg University Hospital, DK-2400 Copenhagen NV, Denmark
Address correspondence to Børge G. Nordestgaard, Department of Clinical Biochemistry 54M1, Herlev Ringvej 75, Herlev University Hospital, DK-2730 Herlev, Denmark. Phone: 45-4488-3297; Fax: 45-4488-3311; email: brno{at}herlevhosp.kbhamt.dk
Reduced levels of wild-type mannose-binding lectin (MBL) may increase susceptibility for infection, other common diseases, and death. We investigated associations between MBL deficiency and risk of infection, other common diseases, and death during 24, 24, and 8 yr of follow-up, respectively. We genotyped 9,245 individuals from the adult Danish population for three MBL deficiency alleles, B, C, and D, as opposed to the normal noncarrier A allele. Hospitalization incidence per 10,000 person · yr was 644 in noncarriers compared with 631 in heterozygotes (log-rank: P = 0.39) and 658 in deficiency homozygotes (P = 0.53). Death incidence per 10,000 person · yr was 235 in noncarriers compared with 244 in heterozygotes (P = 0.44) and 274 in deficiency homozygotes (P = 0.12). After stratification by specific cause of hospitalization or death, only hospitalization from cardiovascular disorders was increased in deficiency homozygotes versus noncarriers (P = 0.02). When retested in two case control studies, this association could not be confirmed. Incidence of hospitalization or death from infections or other serious common disorders did not differ between deficiency homozygotes and noncarriers. In conclusion, in this large study in an ethnically homogenous Caucasian population, there was no evidence for significant differences in infectious disease or mortality in MBL-deficient individuals versus controls. Our results suggest that MBL deficiency is not a major risk factor for morbidity or death in the adult Caucasian population.
Key Words: complement mannan innate immunity infection genetics
Abbreviations used in this paper: CI, confidence interval; ICVD, ischemic cerebrovascular disease; IHD, ischemic heart disease; MBL, mannose-binding lectin.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Christiansen, O. B., Nielsen, H. S., Lund, M., Steffensen, R., Varming, K.
(2009). Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Hum Reprod
24: 291-299
[Abstract]
[Full Text]
-
Benn, M., Schwartz, M., Nordestgaard, B. G., Tybjaerg-Hansen, A.
(2008). Mitochondrial Haplogroups: Ischemic Cardiovascular Disease, Other Diseases, Mortality, and Longevity in the General Population. Circulation
117: 2492-2501
[Abstract]
[Full Text]
-
Kamesh, L., Heward, J. M., Williams, J. M., Gough, S. C. L., Savage, C. O. S., Harper, L.
(2007). Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis. Rheumatology (Oxford)
46: 1076-1078
[Abstract]
[Full Text]
-
Orsted, D. D., Bojesen, S. E., Tybjaerg-Hansen, A., Nordestgaard, B. G.
(2007). Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. JEM
204: 1295-1301
[Abstract]
[Full Text]
-
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjaerg-Hansen, A., Nordestgaard, B. G.
(2007). C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
175: 250-255
[Abstract]
[Full Text]
-
Bossuyt, X., Moens, L., Van Hoeyveld, E., Jeurissen, A., Bogaert, G., Sauer, K., Proesmans, M., Raes, M., De Boeck, K.
(2007). Coexistence of (Partial) Immune Defects and Risk of Recurrent Respiratory Infections. Clin. Chem.
53: 124-130
[Abstract]
[Full Text]
-
Hansen, T. K., Gall, M.-A., Tarnow, L., Thiel, S., Stehouwer, C. D., Schalkwijk, C. G., Parving, H.-H., Flyvbjerg, A.
(2006). Mannose-binding lectin and mortality in type 2 diabetes.. Arch Intern Med
166: 2007-2013
[Abstract]
[Full Text]
-
Hansson, G. K.
(2006). Epidemiology Complements Immunology in the Heart. Arterioscler. Thromb. Vasc. Bio.
26: 2178-2180
[Full Text]
-
Keller, T. T., van Leuven, S. I., Meuwese, M. C., Wareham, N. J., Luben, R., Stroes, E. S., Hack, C. E., Levi, M., Khaw, K.-T., Boekholdt, S. M.
(2006). Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women. Arterioscler. Thromb. Vasc. Bio.
26: 2345-2350
[Abstract]
[Full Text]
-
Verdu, P., Barreiro, L. B., Patin, E., Gessain, A., Cassar, O., Kidd, J. R., Kidd, K. K., Behar, D. M., Froment, A., Heyer, E., Sica, L., Casanova, J.-L., Abel, L., Quintana-Murci, L.
(2006). Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet
15: 2650-2658
[Abstract]
[Full Text]
-
Hjelmesaeth, J., Ueland, T., Flyvbjerg, A., Bollerslev, J., Leivestad, T., Jenssen, T., Hansen, T. K., Thiel, S., Sagedal, S., Roislien, J., Hartmann, A.
(2006). Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients. J. Am. Soc. Nephrol.
17: 1746-1754
[Abstract]
[Full Text]
-
Ruskamp, J. M., Hoekstra, M. O., Rovers, M. M., Schilder, A. G. M., Sanders, E. A. M.
(2006). Mannose-binding lectin and upper respiratory tract infections in children and adolescents: a review.. Arch Otolaryngol Head Neck Surg
132: 482-486
[Abstract]
[Full Text]
-
Dahl, M, Nordestgaard, B G, Seersholm, N
(2005). {alpha}1-Antitrypsin genotype unaffected by age * Authors' reply. Thorax
60: 258-259
[Full Text]
-
Saevarsdottir, S., Oskarsson, O. O., Aspelund, T., Eiriksdottir, G., Vikingsdottir, T., Gudnason, V., Valdimarsson, H.
(2005). Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. JEM
201: 117-125
[Abstract]
[Full Text]
-
Casanova, J.-L., Abel, L.
(2004). Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?. JEM
199: 1295-1299
[Abstract]
[Full Text]